FDA slams Dollar Tree for purchasing drugs from suppliers with checkered safety records

Amid growing concerns over the pharmaceutical supply chain, regulators sternly warned the Dollar Tree (DLTR), which runs a vast network of stores serving mostly low-income communities, for selling over-the-counter medicines made by companies that failed to ensure the drugs were safely manufactured and tested.

In a Nov. 6 warning letter, the Food and Drug Administration noted the retailer purchased medicines from foreign companies that failed to follow manufacturing standards and displayed a pattern of serious violations. These included a failure to test raw materials and finished products, and falsifying test results and releasing sub-potent drugs to the U.S. market. One company had rodent feces throughout its facility, according to the letter, which was posted on the FDA website Thursday.

Read the rest…

Read Original Article: FDA slams Dollar Tree for purchasing drugs from suppliers with checkered safety records »